World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

Abstract

COGNITIVE BEHAVIOUR THERAPY, MULTI-CONVERGENT THERAPY, AND THE MOOD AND COGNITIVE PERFORMANCE OF CHRONIC FATIGUE SYNDROME PATIENTS

Andrew P. Smith* and Marie Thomas

ABSTRACT

Background: Cognitive Behaviour Therapy (CBT) has been recommended as a suitable treatment for chronic fatigue syndrome (CFS). However, recently it has been suggested that the efficacy of CBT is limited, and there is little evidence that it changes objective outcomes. Objectives: The aim of the present analyses were to determine whether group CBT changed the mood and cognitive performance of CFS patients. CBT was compared to two conditions from the same study, namely education and support and standard medical care. Further analyses compared these conditions with a longitudinal study of untreated CFS patients, healthy controls and those having Multi-Convergent Therapy (MCT). Methods: CFS patients were referred to a pain management clinic and randomly assigned to CBT (N=53), education and support (N=49) or standard medical care (N=49). Mood and cognitive performance were measured pre-treatment and again at six and twelve months post-treatment. Comparisons were also made with a sample of untreated CFS patients (N = 195) and those who had participated in a study of MCT (N=35). Results: At baseline, the CFS patients showed the usual differences from healthy controls, namely a more negative mood, slower reaction times, and impaired recall and sustained attention. Analyses of the post-treatment data revealed little evidence of CBT leading to significant changes. In contrast, MCT was associated with significant improvements in mood and performance. Conclusions: Group CBT leads to a significant reduction in subjective symptoms but does not improve cognitive performance, whereas individual MCT does improve mood and performance.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR